Lung Cancer Update cover image

Striving for Consensus on the Management of ALK-Positive Lung Cancer

Lung Cancer Update

00:00

The Neurocognitive Effects of Lore Latinib

ABI de Gogo Jackiner group recently published a paper trying to look at factors associated with the neurocognitive and mood effects of lore latinib. I think electinib or bergatin both would be perfectly acceptable agents. The toxicity is manageable with dose dose reduction, but docs need to use drugs that they're familiar with managing.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app